Making Medicine in America Again: Why Breaking Monopolies Is Key to Building a Resilient U.S. Pharmaceutical Manufacturing Base

Healthcare

March 4, 2026 — This paper explains the risks of U.S. dependence on foreign countries for essential medicines and tells the history of how we got here, discusses how successful onshoring of pharmaceutical manufacturing requires restructuring markets by reining in the market power and anti-competitive practices of pharmaceutical middlemen, sets forth a vision and plan for incorporating antimonopoly by design to build deconcentrated pharmaceutical manufacturing market structures, and discusses trade policies to be implemented as competition policies restructure markets and as industrial policies invest in, and create reliable demand for, domestic manufacturing.

UnitedHealth Group Is a Bank: How Policymakers Can Protect Independent Physician Practices from Becoming Loan Shark Bait

Healthcare

December 18, 2025 — This analysis documents how UnitedHealth Group's FDIC-insured industrial bank, something that has largely been overlooked in debates over health care consolidation, has become another lever the company uses to push independent practices toward financial dependence, closure, or sale, often during moments of acute distress and volatility.

Within Earshot: Overcoming Barriers to Over-the Counter Hearing Aid Access

Healthcare

November 24, 2025 — This report explores why reforms to date have not produced widespread adoption and what steps policymakers and private actors can take to spur further use. Specifically, it provides an overview of the extremely consolidated hearing aid market; outlines barriers to broader consumer adoption, including consumer concerns about purchasing a medical device without the assistance of a licensed professional, retailer concerns about such consumer reluctance, and a widespread lack of insurance coverage for OTC hearing aids; and recommends policy solutions, including reversing the vertical integration in the hearing industry and eliminating its inherent conflicts of interests while expanding insurance coverage, particularly within Medicare.

HHS Policy Recommendations to Combat Consolidated Corporate Power

Healthcare

February 24, 2025 — The American Economic Liberties Project (AELP) compiled this memo outlining how the second Trump administration, and especially the U.S. Department of Health and Human Services (HHS), can fulfill its promises to voters by reining in the consolidated corporate power imperiling Americans’ health.

America’s Health Care Consolidation Crisis: A Ledger of Harms and Framework for Advancing Economic Liberty for All

Healthcare

October 24, 2024 — The American Economic Liberties Project has compiled a ledger of harms to chronicle the research showing both the extent of health care’s concentration crisis and how it hurts patients, providers, and other market participants. We also offer several policy suggestions for restoring healthy competition.